🆂🆃🆄🅳🆈 - 𝕍𝕒𝕔𝕔𝕚𝕟𝕖𝕤 𝕔𝕦𝕥 ℂ𝕆𝕍𝕀𝔻-𝟙𝟡 𝕥𝕣𝕒𝕟𝕤𝕞𝕚𝕤𝕤𝕚𝕠𝕟 𝕓𝕪 𝕦𝕡 𝕥𝕠 𝕙𝕒𝕝f

The Foote Grandchildren wish they had a grand father who believed in the efficacy of covid vaccines.

ℂ𝕆𝕍𝕀𝔻-𝟙𝟡 𝕧𝕒𝕔𝕔𝕚𝕟𝕖𝕤 𝕕𝕖𝕡𝕝𝕠𝕪𝕖𝕕 𝕚𝕟 𝔼𝕟𝕘𝕝𝕒𝕟𝕕 𝕔𝕒𝕟 𝕔𝕦𝕥 𝕥𝕣𝕒𝕟𝕤𝕞𝕚𝕤𝕤𝕚𝕠𝕟 𝕠𝕗 𝕥𝕙𝕖 𝕔𝕠𝕣𝕠𝕟𝕒𝕧𝕚𝕣𝕦𝕤 𝕚𝕟 𝕙𝕠𝕦𝕤𝕖𝕙𝕠𝕝𝕕𝕤 𝕓𝕪 𝕦𝕡 𝕥𝕠 𝕒 𝕙𝕒𝕝𝕗, 𝕕𝕒𝕥𝕒 𝕗𝕣𝕠𝕞 ℙ𝕦𝕓𝕝𝕚𝕔 ℍ𝕖𝕒𝕝𝕥𝕙 𝔼𝕟𝕘𝕝𝕒𝕟𝕕 (ℙℍ𝔼) 𝕤𝕙𝕠𝕨𝕖𝕕 𝕠𝕟 𝕎𝕖𝕕𝕟𝕖𝕤𝕕𝕒𝕪, 𝕚𝕟 𝕒𝕕𝕕𝕚𝕥𝕚𝕠𝕟 𝕥𝕠 𝕥𝕙𝕖 𝕡𝕣𝕠𝕥𝕖𝕔𝕥𝕚𝕠𝕟 𝕥𝕙𝕖 𝕤𝕙𝕠𝕥𝕤 𝕠𝕗𝕗𝕖𝕣 𝕒𝕘𝕒𝕚𝕟𝕤𝕥 𝕤𝕪𝕞𝕡𝕥𝕠𝕞𝕒𝕥𝕚𝕔 𝕚𝕟𝕗𝕖𝕔𝕥𝕚𝕠𝕟.

The research offers insight on one of the big unknowns over COVID-19 vaccinations - the extent to which they prevent transmission of the coronavirus - and could strengthen the case for Prime Minister Boris Johnson plans to end England's lockdown in June.

"We already know vaccines save lives and this study is the most comprehensive real-world data showing they also cut transmission of this deadly virus," health minister Matt Hancock said.

.

.

New research showed that people who became infected with the coronavirus three weeks after receiving one dose of Pfizer or AstraZeneca vaccine were between 38 percent to 49 percent less likely to pass it on to household contacts compared to those who were unvaccinated.

The shots also stop a vaccinated person developing symptomatic infection to start with, reducing the risk by around 60 percent to 65 percent from four weeks after one dose of either vaccine.

Popular Bull ring poster adored by all the screw-ball right wing freaks receives his second Covid 19 vaccine

"While these findings are very encouraging, even if you have been vaccinated, it is really important that you continue to act like you have the virus," said Mary Ramsay, head of immunisation at PHE.

The study included over 57,000 contacts from 24,000 households in which there was a lab-confirmed case that had received a vaccination, PHE said, compared with nearly 1 million contacts of unvaccinated cases.

.

.

Britain has one of the fastest COVID-19 vaccine rollouts in the world, with over 33.8 million first doses given and a quarter of adults receiving both shots.

That has generated real-world data on how Pfizer and AstraZeneca work outside the setting of clinical trials, and earlier this month PHE said the rollout had prevented over 10,000 deaths of people aged 60 and older by the end of March.

Previous data that showed good effectiveness of vaccines in older people helped inform other countries who reversed age limits on AstraZeneca's shot.

.